In the past 3 months, how many early-stage (non-metastatic or Stages 1-3) Non-small cell lung cancer patients received the following treatments:
1. Atezolizumab
2. Durvalumab
3. Nivolumab
4. Pembrolizumab
5. Chemotherapy (Platinum, Taxane, Vinorelbine, Gemcitabine, Pemetrexed) only
6. Radiotherapy only
7. Chemotherapy + radiotherapy
